2m 2m 2m 2m 2m 2m 2m
BRIGHT MINDS (DRUG)
NASDAQ
$75.53-$0.40 (-0.53%)
Price as of Jul 14, 2026 9:59 AM EDT- $745.0MMarket Cap
- 196.02%1-Year Change
- BiotechnologyIndustry
BRIGHT MINDS (DRUG)
$75.53-$0.40 (-0.53%)
DRUG | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $75.93 | ||
Change | -$1.91 (-2.45%) | ||
Open | $76.44 | ||
High | $77.09 | ||
Low | $73.01 | ||
Previous Close | $77.84 | ||
Volume | 389,931 | ||
30-Day Average Volume | 325,191 | ||
1-Week Change | 13.92% | ||
1-Month Change | 24.58% | ||
1-Year Change | 196.02% | ||
3-Year Change | 2,469.54% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 9.8M | ||
Total Assets | $84.4M | ||
Market Cap | $745.0M | ||
Enterprise Value | $662.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 5 | ||
Last Split Date | 07/14/2023 | ||
Earnings & Revenue